EspeRare, their partner Pierre Fabre Group and the UK patient association will be presenting at the Drug Repurposing for Rare Diseases Conference in London on October 10th 2022 on how they are joining forces to reposition and develop a landmark treatment in XLHED.
EspeRare will also present its pioneering new collaborative model centered on patients and integrating the ethical commitment in terms of the accessibility to treatments for rare disease community.
This annual conference, live and in-person since 2020 highlights the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments.
For more information on the DrugRepo 2022, please follow the link.
